Free FDA’s Critics Call for Full Integration of Oncology Center Under Biden’s Moonshot The White House moonshot to accelerate progress in cancer research directs FDA to consolidate its oncology portfolio.May 06, 2016Vol.42 No.18By Matthew Bin Han Ong